LEMAITRE VASCULAR, INC. Deferred Tax Assets, Capital Loss Carryforwards
LEMAITRE VASCULAR, INC. (LMAT) had Deferred Tax Assets, Capital Loss Carryforwards of $453.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Capital Loss Carryforwards $453.00K.
- 2024-12-31: Deferred Tax Assets, Capital Loss Carryforwards $422.00K.
- 2023-12-31: Deferred Tax Assets, Capital Loss Carryforwards $462.00K.
- 2022-12-31: Deferred Tax Assets, Capital Loss Carryforwards $462.00K.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards |
|---|---|
| 2025-12-31 | $453.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $422.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $462.00K 10-K · filed 2025-02-28 |
| 2022-12-31 | $462.00K 10-K · filed 2024-02-29 |
| 2021-12-31 | $492.00K 10-K · filed 2023-03-01 |
| 2020-12-31 | $521.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $277.00K 10-K · filed 2021-03-12 |
| 2018-12-31 | $279.00K 10-K · filed 2020-03-12 |
| 2017-12-31 | $1.17M 10-K · filed 2019-03-11 |
| 2016-12-31 | $1.08M 10-K · filed 2018-03-09 |
| 2015-12-31 | $1.09M 10-K · filed 2017-03-09 |
| 2014-12-31 | $1.31M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |